Stockreport

GSK Advances Respiratory And Vaccine Growth With Key RSV And Asthma Moves [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF GSK (LSE:GSK) received European approval to broaden the age indication for its RSV vaccine Arexvy, expanding eligible adults beyond the original target group. The com [Read more]